CSC
GILD icon

Caldwell Sutter Capital’s Gilead Sciences GILD Stock Holding History

Caldwell Sutter Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930K Sell
7,357
-233
-3% -$30.7K 0.35% 71
2026
Q1 		$1.06M Sell
7,590
-504
-6% -$70.6K 0.43% 62
2025
Q4 		$993K Sell
8,094
-214
-3% -$26K 0.42% 63
2025
Q3 		$922K Sell
8,308
-478
-5% -$54.3K 0.39% 66
2025
Q2 		$974K Sell
8,786
-224
-2% -$23.8K 0.45% 59
2025
Q1 		$1.01M Sell
9,010
-697
-7% -$71.9K 0.48% 55
2024
Q4 		$897K Sell
9,707
-81
-0.8% -$7.29K 0.42% 64
2024
Q3 		$821K Sell
9,788
-452
-4% -$34.5K 0.38% 69
2024
Q2 		$703K Buy
10,240
+503
+5% +$33.6K 0.35% 81
2024
Q1 		$713K Sell
9,737
-51
-0.5% -$3.92K 0.34% 82
2023
Q4 		$793K Sell
9,788
-146
-1% -$11.4K 0.4% 67
2023
Q3 		$744K Sell
9,934
-167
-2% -$12.8K 0.41% 69
2023
Q2 		$779K Buy
10,101
+5,476
+118% +$437K 0.41% 72
2023
Q1 		$384K Buy
4,625
+4,155
+884% +$344K 0.28% 84
2022
Q4 		$40.4K Buy
+470
New +$37.2K 0.04% 189

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caldwell Sutter Capital's GILD Position: Q2 2026 in Review

Caldwell Sutter Capital reduced its Gilead Sciences (GILD) stake by 3.1% in Q2 2026, selling an estimated $30.7K and leaving 7,357 shares worth $930K. The position accounts for 0.35% of the portfolio, ranked #71.

Caldwell Sutter Capital first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.06M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Caldwell Sutter Capital held 7,357 shares of Gilead Sciences worth $930K as of Q2 2026.
  • Caldwell Sutter Capital sold 233 Gilead Sciences shares in Q2 2026, an estimated $30.7K.
  • Gilead Sciences made up 0.35% of Caldwell Sutter Capital's portfolio in Q2 2026, its #71 holding.
  • Caldwell Sutter Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Caldwell Sutter Capital's Gilead Sciences position peaked at $1.06M in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.